Extor, Pa.

Went public 8/4/2000 at $15 per share

Filing Range: 4 mil. shares @ $13 to $15

Share Outstanding: 18.2 mil. shares

Underwriters: Bear, Stearns & Co. Inc./Chase H&Q/U.S. Bancorp Piper


Company Counsel: Morgan Lewis & Bockius

Manager Counsel: Coudert Brothers

Auditor: Richard A. Eisner & Co. LLP

The Company:

Uses its DiscoverWorks technology to identify small-molecule drug candidates by using such features as protein production, high-throughput screening, a library of some 200,000 chemical compounds and 2.5 billion novel analogs and 3-D target protein structure analysis to expedite the process. The company is also developing a pipeline of cardiovascular and oncology drug candidates, which it plans to license out in the early trial stages.

Venture Backers:

MPM Asset Management LLC

Rho Management

Healthcare Ventures LLC

Abingworth Management Ltd.

State of Michigan Retirement Systems

Philadelphia Ventures Inc.

SENMED Medical Ventures

M&G Group

Aetna Life & Casualty

Financing Rounds:

Number of Round Amt.

Round # Round Date Stage Investors ($ thousands)

1 10/01/1996 2 Early Stage 5418.0

2 03/12/1997 7 Early Stage 12500.1

3 01/06/1998 2 Later Stage 10800.0

4 11/18/1999 2 Later Stage 500.0

5 03/21/2000 9 Expansion 18533.0


(Data in $ millions)



Total Revenues: $4.5

Net Income: -16.0